27/11/2014 22:08:19 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
11/24/20146:00AMPRNUSInovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market PR Newswire PLYMOUTH MEETING, Pa., Nov. 24, 2014 PLYMOUTH MEETING, Pa., Nov. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that Dr. J. Joseph Kim, President and CEO of Inovio Pharmaceuticals, will be joined... More...>>
11/20/20148:00AMPRNUSInovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study
Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PR Newswire PLYMOUTH MEETING, Pa., Nov. 20, 2014 PLYMOUTH MEETING, Pa., Nov. 20, 2014 /PRNewswire/ -- Inovio Pharmaceuticals... More...>>
11/17/20143:00AMPRNUSInovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreem...
Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy PR Newswire PLYMOUTH MEETING, Pa., Nov. 17, 2014 PLYMOUTH MEETING, Pa., Nov. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:... More...>>
11/11/20146:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 11, 2014 PLYMOUTH MEETING, Pa., Nov. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that Dr. J. Joseph Kim, President & CEO, will present a corporate overview at the upcoming Stifel Healthcare... More...>>
11/10/20146:00AMPRNUSInovio Pharmaceuticals Reports 2014 Third Quarter Financial Results
Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results PR Newswire PLYMOUTH MEETING, Pa., Nov. 10, 2014 PLYMOUTH MEETING, Pa., Nov. 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today reported financial results for the quarter ended September 30, 2014. Total revenue was $1.8 million and... More...>>
11/04/20146:00AMPRNUSInovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014
Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014 PR Newswire PLYMOUTH MEETING, Pa., Nov. 4, 2014 PLYMOUTH MEETING, Pa., Nov. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it will host a conference call and live webcast to report its third... More...>>
10/21/20146:00AMPRNUSInovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac...
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria PR Newswire PLYMOUTH MEETING, Pa., Oct. 21, 2014 PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the Defense Advanced Research... More...>>
09/30/20147:00AMPRNUSInovio Pharmaceuticals Appoints Vice President of Commercial Development
Inovio Pharmaceuticals Appoints Vice President of Commercial Development New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble PR Newswire PLYMOUTH MEETING, Pa., Sept. 30, 2014 PLYMOUTH MEETING, Pa., Sept. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced... More...>>
09/24/201410:41AMDJNCorrection to Inovio, GeneOne Headline
"Inovia, GeneOne to Advance Ebola Vaccine to Human Trials," at 8:41 a.m. EDT, misstated the name of company in the headline. The company is Inovio, not Inovia. Subscribe to WSJ: http://online.wsj.com?mod=djnwires More...>>
09/24/20149:50AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Wednesday's session are Citizens Financial Group Inc. (CFG), Newell Rubbermaid Inc. (NWL) and Acorda Therapeutics Inc. (ACOR). Citizens Financial, a U.S. unit of Royal Bank of Scotland Group PLC (RBS, RBS.LN), is expected to begin trading on Wednesday after... More...>>
09/24/20146:00AMPRNUSInovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science
Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science PR Newswire PLYMOUTH MEETING, Pa., Sept. 24, 2014 PLYMOUTH MEETING, Pa., Sept. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in... More...>>
09/22/20148:00AMPRNUSInovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers Expansion Comes After Successful Phase II Trial for Cervical Dysplasia PR Newswire PLYMOUTH MEETING, Pa., Sept. 22, 2014 PLYMOUTH MEETING, Pa., Sept. 22, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today... More...>>
09/18/20146:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Sept. 18, 2014 PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's... More...>>
09/04/20149:00AMPRNUSInovio Pharmaceuticals to List on NASDAQ
Inovio Pharmaceuticals to List on NASDAQ PR Newswire PLYMOUTH MEETING, Pa., Sept. 4, 2014 PLYMOUTH MEETING, Pa., Sept. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will transfer its U.S. stock exchange... More...>>
09/03/20148:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Sept. 3, 2014 PLYMOUTH MEETING, Pa., Sept. 3, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the... More...>>
08/11/20148:30AMPRNUSInovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results HPV Immune Therapy VGX-3100 to Advance into Phase III PR Newswire PLYMOUTH MEETING, Penn., Aug. 11, 2014 PLYMOUTH MEETING, Penn., Aug. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter... More...>>
08/06/20145:16PMPRNUSINOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible...
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc. PR Newswire NEW YORK, Aug. 6, 2014 NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating... More...>>
08/01/20148:00AMPRNUSInovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 PR Newswire PLYMOUTH MEETING, Pa., Aug. 1, 2014 PLYMOUTH MEETING, Pa., Aug. 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014... More...>>
07/23/20149:15AMPRNUSInovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PR Newswire PLYMOUTH MEETING, Pa., July 23, 2014 PLYMOUTH MEETING... More...>>
07/01/20144:00AMPRNUSInovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes
Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes Inovio Shares Enter No. 1 U.S. Equity Index for Asset Benchmarking PR Newswire PLYMOUTH MEETING, Pa., July 1, 2014 PLYMOUTH MEETING, Pa., July 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino141127 22:08